ES2097151T3 - Agonistas parciales del sitio modulador de la glicina, insensible a estricnina, del complejo receptor de n-metil-d-aspartato, como agentes neuropsicofarmacologicos. - Google Patents
Agonistas parciales del sitio modulador de la glicina, insensible a estricnina, del complejo receptor de n-metil-d-aspartato, como agentes neuropsicofarmacologicos.Info
- Publication number
- ES2097151T3 ES2097151T3 ES90911501T ES90911501T ES2097151T3 ES 2097151 T3 ES2097151 T3 ES 2097151T3 ES 90911501 T ES90911501 T ES 90911501T ES 90911501 T ES90911501 T ES 90911501T ES 2097151 T3 ES2097151 T3 ES 2097151T3
- Authority
- ES
- Spain
- Prior art keywords
- methyl
- receptor complex
- partial agonists
- stricnin
- neuropsycho
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title abstract 4
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 title abstract 3
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 title abstract 3
- 239000004031 partial agonist Substances 0.000 title abstract 3
- 239000004471 Glycine Substances 0.000 title abstract 2
- 239000002831 pharmacologic agent Substances 0.000 title 1
- PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical compound OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 abstract 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 abstract 2
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 241001279009 Strychnos toxifera Species 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960005453 strychnine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/390,745 US6017957A (en) | 1989-08-08 | 1989-08-08 | Partial agonists of the strychnine insensitive glycine modulatory site of the N-methyl-D-aspartate receptor complex as neuropsychopharmacological agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2097151T3 true ES2097151T3 (es) | 1997-04-01 |
Family
ID=23543754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES90911501T Expired - Lifetime ES2097151T3 (es) | 1989-08-08 | 1990-08-02 | Agonistas parciales del sitio modulador de la glicina, insensible a estricnina, del complejo receptor de n-metil-d-aspartato, como agentes neuropsicofarmacologicos. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6017957A (de) |
| EP (1) | EP0485431B1 (de) |
| JP (1) | JP2598570B2 (de) |
| AT (1) | ATE148989T1 (de) |
| AU (1) | AU639252B2 (de) |
| CA (1) | CA2059526C (de) |
| DE (1) | DE69029967T2 (de) |
| DK (1) | DK0485431T3 (de) |
| ES (1) | ES2097151T3 (de) |
| WO (1) | WO1991001729A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| JPH07505908A (ja) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Ｎｍｄａ受容体のアロステリックモジュレーター |
| US5854217A (en) * | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
| US5428069A (en) * | 1993-01-11 | 1995-06-27 | The United States Of America As Represented By The Department Of Health & Human Services | Treating cognition with, aminocyclopropanecarboxylic derivatives |
| AU4019395A (en) * | 1994-11-23 | 1996-06-17 | G.D. Searle & Co. | Use of amino-isoxazolidone compounds for improvement of implicit memory |
| RU2106864C1 (ru) * | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | Средство для лечения болезни альцгеймера |
| IL118657A0 (en) * | 1996-06-14 | 1996-10-16 | Arad Dorit | Inhibitors for picornavirus proteases |
| US6172041B1 (en) | 1996-07-22 | 2001-01-09 | University Of Utah Research Foundation | Use of conantokins |
| CA2261568A1 (en) | 1996-07-22 | 1998-01-29 | University Of Utah Research Foundation | Conantokins |
| US6277825B1 (en) | 1996-07-22 | 2001-08-21 | University Of Utah Research Foundation | Use of conantokins for treating pain |
| US6399574B1 (en) | 2000-03-22 | 2002-06-04 | University Of Utah Research Foundation | Use of conantokins |
| US7001911B2 (en) * | 2000-06-28 | 2006-02-21 | Bristol-Myers Squibb Company | Fused cyclic modulators of nuclear hormone receptor function |
| RU2283108C2 (ru) * | 2003-12-08 | 2006-09-10 | Сергей Олегович Бачурин | ГЕРОПРОТЕКТОР НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| US20070179174A1 (en) * | 2003-12-08 | 2007-08-02 | Bachurin Sergei O | Methods and compositions for slowing aging |
| CN1293868C (zh) * | 2004-12-29 | 2007-01-10 | 朱旭祥 | α－环丙氨酸在制备治疗心脑血管疾病药物中的应用 |
| EP1893576A4 (de) * | 2005-05-27 | 2010-03-17 | Univ Kingston | Behandlung von proteinfaltungsstörungen |
| EP1937263A2 (de) * | 2005-10-04 | 2008-07-02 | Medivation, Inc. | Hydrierte pyrido-indol-verbindungen zur behandlung von morbus huntington |
| US7531572B2 (en) * | 2006-07-28 | 2009-05-12 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of α-amino acids, methods of synthesis and use |
| US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554017A (en) * | 1978-06-03 | 1985-11-19 | Bayer Aktiengesellschaft | Method and compositions for regulating plant growth using cycloalkane-carboxylic acid compounds |
| FR2508033A1 (fr) * | 1981-06-23 | 1982-12-24 | Fabre Sa Pierre | Aryl-1 aminomethyl-2 cyclopropanes carboxylates (z), leur preparation et leur application en tant que medicaments utiles dans le traitement d'algies diverses |
| US4491589A (en) * | 1982-05-17 | 1985-01-01 | The Trustees Of Columbia University In The City Of New York | Amino acid solutions for parenteral nutrition and methods of formulation and use |
| US4746653A (en) * | 1986-02-28 | 1988-05-24 | Ciba-Geigy Corporation | Certain hetero phosphonic acid derivatives of 2-piperidine or 2-tetrahydropyridinecarboxylates and esters thereof which are useful for the treatment of disorders responsive to blockade of the NMDA receptor in mammals |
| US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
-
1989
- 1989-08-08 US US07/390,745 patent/US6017957A/en not_active Expired - Fee Related
-
1990
- 1990-08-02 AT AT90911501T patent/ATE148989T1/de not_active IP Right Cessation
- 1990-08-02 JP JP2511131A patent/JP2598570B2/ja not_active Expired - Fee Related
- 1990-08-02 CA CA002059526A patent/CA2059526C/en not_active Expired - Fee Related
- 1990-08-02 ES ES90911501T patent/ES2097151T3/es not_active Expired - Lifetime
- 1990-08-02 DE DE69029967T patent/DE69029967T2/de not_active Expired - Fee Related
- 1990-08-02 WO PCT/US1990/004246 patent/WO1991001729A1/en not_active Ceased
- 1990-08-02 AU AU61434/90A patent/AU639252B2/en not_active Ceased
- 1990-08-02 EP EP90911501A patent/EP0485431B1/de not_active Expired - Lifetime
- 1990-08-02 DK DK90911501.6T patent/DK0485431T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0485431A4 (en) | 1992-08-12 |
| JP2598570B2 (ja) | 1997-04-09 |
| JPH05501868A (ja) | 1993-04-08 |
| WO1991001729A1 (en) | 1991-02-21 |
| DE69029967T2 (de) | 1997-05-28 |
| ATE148989T1 (de) | 1997-03-15 |
| DK0485431T3 (da) | 1997-08-25 |
| EP0485431B1 (de) | 1997-02-19 |
| AU639252B2 (en) | 1993-07-22 |
| EP0485431A1 (de) | 1992-05-20 |
| US6017957A (en) | 2000-01-25 |
| DE69029967D1 (de) | 1997-03-27 |
| AU6143490A (en) | 1991-03-11 |
| CA2059526C (en) | 1996-12-17 |
| CA2059526A1 (en) | 1991-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0485431A4 (en) | Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents | |
| CY1120313T1 (el) | Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει βιταμινη d και κορτικοστεοειδες | |
| YU7797A (sh) | Kombinovana terapija za osteoporozu | |
| ATE236654T1 (de) | Therapeutische kombinationen von rar-antagonisten und rxr-agonisten | |
| AP9901531A0 (en) | Method and novel compounds for use therein. | |
| GT199800158AA (es) | Agonistas de prostaglandinas y su uso para tratar trastornos oseos | |
| BR9408063A (pt) | Antagonistas de receptores de taquicinina que nÆo sÆo pept¡deos | |
| ES2063073T3 (es) | Derivados de arilmetilenilo conocidos y nuevos seleccionados de tiazolidinonas, imidazolidinonas y oxazolidinonas utiles como agentes antialergicos y agentes antiinflamatorios. | |
| GT199700095A (es) | Derivados 6,5-heterobiciclicos sustituidos. | |
| DE69533180D1 (de) | Steroidrezeptor-Modulator Verbindungen und Methoden | |
| MX9305294A (es) | Compuestos de decahidroisoquinolina, procedimiento para su preparacion y formulacion farmaceutica que los comprende. | |
| ES8505519A1 (es) | Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos. | |
| BR0307429A (pt) | Composto, uso do mesmo, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com receptor de histamina h3 | |
| MX9204881A (es) | Composicion farmaceutica que comprende moleculas activas, receptoras de calcio. | |
| NO951613L (no) | Ikke-peptidyl tachykinin reseptorantagonister | |
| CA2085135A1 (en) | Treatment of Mood Disorders with Functional Antagonists of the Glycine/NMDA Receptor Complex | |
| PA8435001A1 (es) | Derivados 6,6-heterobiciclicos sustituidos. | |
| GR1000392B (el) | Σταθεροποιημενες συνθεσεις περιεχουσες επιδερμικο παραγοντα αναπτυξης. | |
| BG106142A (en) | Glucocorticoid receptor modulators | |
| GT199700107A (es) | Lactamas e imidas heterociclicas de aralquilo y araquilideno | |
| BG101110A (bg) | Заместени пиримидинови съединения и тяхното използване | |
| EA200200132A1 (ru) | СЕЛЕКТИВНЫЕ АНТАГОНИСТЫ РЕЦЕПТОРА iGluRДЛЯ ЛЕЧЕНИЯ МИГРЕНИ | |
| BR0008302A (pt) | Uso de um derivado de benzaldeìdo, derivado de benzaldeìdo, composição farmacêutica, e, processo para a fabricação da mesma | |
| DE69330754D1 (de) | 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ[b]AZEPINE ALS NMDA REZEPTOR ANTAGONISTEN | |
| DK0417003T3 (da) | Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 485431 Country of ref document: ES |